Literature DB >> 32232928

Molecular signatures of extracellular vesicles in oral fluids of periodontitis patients.

Alejandra Chaparro Padilla1, Laura Weber Aracena1, Ornella Realini Fuentes1, Daniela Albers Busquetts2, Marcela Hernández Ríos3, Valeria Ramírez Lobos4, Andrés Pascual la Rocca5, José Nart Molina5, Victor Beltrán Varas6, Stephanie Acuña-Gallardo7, Antonio Sanz Ruiz1.   

Abstract

OBJECTIVE: To characterize extracellular vesicles (EVs) in gingival crevicular fluid (GCF) and saliva samples from healthy/gingivitis and periodontitis patients and correlate them with clinical inflammatory periodontal parameters. MATERIAL AND
METHOD: An exploratory study, including 86 subjects was conducted. Clinical and periodontal data were recorded and oral fluids samples were obtained. EVs were precipitated by ExoQuick-TC™ and characterized by nanoparticle tracking analysis (Nanosight™), western-blot (WB), transmission electron microscopy (TEM) and ELISA.
RESULTS: TEM showed nanoparticles morphologically compatible with EVs and WB analysis revealed bands of specific EVs markers (CD9, TSG101, Alix) in both oral fluids of periodontitis and healthy/gingivitis subjects. The total concentration of EVs in GCF was increased in periodontitis patients compared to healthy/gingivitis subjects (p=0.017). However, we did not observe differences in the EVs concentration of saliva samples (p=0.190). The size of GCF-EVs was 144.2nm in periodontitis and 160.35nm in healthy/gingivitis patients (p=0.038). The CD63 exosome marker was increased in GCF of periodontitis patients (p=0.00001). The total concentration of EVs in GCF was correlated with bleeding on probing (rho=0.63, p=0.002), periodontal probing depth (rho=0.56, p=0.009) and clinical attachment level (rho=0.48, p=0.030).
CONCLUSION: periodontitis patients have increased concentration of EVs in GCF and their role in periodontitis should be clarified. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  exosomes; extracellular vesicles; micro-vesicles; periodontitis

Year:  2020        PMID: 32232928     DOI: 10.1111/odi.13338

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  6 in total

Review 1.  Breast Cancer Derived Extracellular Vesicles in Bone Metastasis Induction and Their Clinical Implications as Biomarkers.

Authors:  Simona Taverna; Ilaria Giusti; Sandra D'Ascenzo; Laura Pizzorno; Vincenza Dolo
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

2.  New Biomarker in Chagas Disease: Extracellular Vesicles Isolated from Peripheral Blood in Chronic Chagas Disease Patients Modulate the Human Immune Response.

Authors:  Rafael Pedro Madeira; Lavínia Maria Dal'Mas Romera; Paula de Cássia Buck; Charles Mady; Barbara Maria Ianni; Ana Claudia Torrecilhas
Journal:  J Immunol Res       Date:  2021-01-11       Impact factor: 4.818

3.  Salivary Outer Membrane Vesicles and DNA Methylation of Small Extracellular Vesicles as Biomarkers for Periodontal Status: A Pilot Study.

Authors:  Pingping Han; Peter Mark Bartold; Carlos Salomon; Sašo Ivanovski
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

Review 4.  Exogenous and Endogenous Dendritic Cell-Derived Exosomes: Lessons Learned for Immunotherapy and Disease Pathogenesis.

Authors:  Mahmoud Elashiry; Ranya Elsayed; Christopher W Cutler
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

Review 5.  Mesenchymal Stem Cell-Derived Extracellular Vesicle: A Promising Alternative Therapy for Osteoporosis.

Authors:  Cheng-Hsiu Lu; Yi-An Chen; Chien-Chih Ke; Ren-Shyan Liu
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

Review 6.  Periodontitis and Gestational Diabetes Mellitus: A Potential Inflammatory Vicious Cycle.

Authors:  María José Bendek; Gisela Canedo-Marroquín; Ornella Realini; Ignacio N Retamal; Marcela Hernández; Anilei Hoare; Dolores Busso; Lara J Monteiro; Sebastián E Illanes; Alejandra Chaparro
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.